Aphria has tanked on short seller accusations that appear to be legitimate and well-researched.
Despite the good research, I find a $0 target on APHA to be a stretch and Gabriel Grego's backtracking on Wednesday's BNN interview supports that opinion.
I expect to play the volatility on both sides of the equation, but for now, I have a long position, speculating on the market's temporary exhaustion of the short thesis.
Until recently, Aphria Inc. (APHA) is not a stock I have paid much attention to. My three second, high-level analysis of the company is that it is one of the larger "typical" licensed